|
2024
|
Invention
|
Mdma enantiomer compositions and methods for modulating aggression response. Disclosed are pharma... |
|
|
Invention
|
Prodrugs of mdma, mda, and derivatives thereof.
The present disclosure provides prodrug compound... |
|
|
Invention
|
Nitric oxide releasing prodrugs of mda and mdma.
Provided herein are compounds of Formula (I), F... |
|
|
Invention
|
Heterocyclic propyl amine modulators of monoaminergic transporters. 123455, V, W, X, Y, and Z are... |
|
2023
|
Invention
|
Salt forms of r-mdma and methods using the same. Pharmaceutical compositions including R-MDMA sal... |
|
|
Invention
|
Synthesis of mda or its optically active (r)- or (s)-mda isomers.
Provided herein is a process f... |
|
|
Invention
|
S)-mda isomers. RSS)-3,4-methylenedioxyamphetamine. |
|
|
Invention
|
Use of mdma for treatment of stress-related disorders.
Methods of treating a stress-related dise... |
|
|
Invention
|
Stable polymorph of r-mdma hcl.
Provided herein is a process for the preparation of (R)-3,4 meth... |
|
2022
|
Invention
|
Nitric oxide releasing prodrugs of mda and mdma. 7 and A are defined herein. Also provided herein... |
|
|
Invention
|
Enantiomeric ratios of 3,4-methylenedioxymethamphetamine and related metabolites and uses thereof... |
|
|
Invention
|
Prodrugs of mdma, mda, and derivatives thereof. The present disclosure provides prodrug compounds... |
|
|
Invention
|
Preparation of optically active enantiomers of piperonyl amines by resolution of the diastereomer... |
|
|
Invention
|
Synthesis of mdma or its optically active (r)- or (s)-mdma isomers. Provided herein is a process ... |
